GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » 6-1 Month Momentum %

Reunion Neuroscience (TSX:REUN) 6-1 Month Momentum % : -13.69% (As of May. 04, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-04), Reunion Neuroscience's 6-1 Month Momentum % is -13.69%.

The industry rank for Reunion Neuroscience's 6-1 Month Momentum % or its related term are showing as below:

TSX:REUN's 6-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: 0.14 vs TSX:REUN: -13.69

Competitive Comparison of Reunion Neuroscience's 6-1 Month Momentum %

For the Biotechnology subindustry, Reunion Neuroscience's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reunion Neuroscience's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reunion Neuroscience's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Reunion Neuroscience's 6-1 Month Momentum % falls into.



Reunion Neuroscience  (TSX:REUN) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Reunion Neuroscience  (TSX:REUN) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Reunion Neuroscience 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Reunion Neuroscience's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Reunion Neuroscience (TSX:REUN) Business Description

Traded in Other Exchanges
N/A
Address
30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3
Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.